Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
CSBA Letter to Congressional Leadership…
Learn more
John F. Crowley, President and CEO of the…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
Learn more
CSBA Letter to Congressional Leadership on Most…
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences Network (WABNet), Senegal
March 10, 2016
Government's role in developing solutions for diseases that disproportionately affect developing countries
Eileen Yen, former Director, Sarawak Biodiversity Centre, Malaysia
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH)
March 10, 2016
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), US Department of Health & Human Services, USA
The Patent Reform Act of 2007 - Coalition Letter
March 10, 2016
More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.
Presentation: "Global Health Challenges: How Industry is Addressing Global Health", presented at the University of Virginia in June 2008
March 10, 2016
Global Health Challenges: How Industry is Addressing Global Health
Ted Roumel, Vice President for Research Innovation & Commercialization at the University of Maryland Biotechnology Institute, USA
March 10, 2016
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT for RESEARCH, INNOVATION AND COMMERCIALIZATION UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
BIO Testimony to the House Judiciary Committee Concerning the Hearing on Patent Reform
March 10, 2016
Comments to the European Food Safety Authority
March 10, 2016
Implications of animal cloning on food safety, animal health and welfare and the environment.
Cloning Recommendation before the National Organic Standards Board
March 10, 2016
Livestock clones and their progeny can be raised in accordance with the Organic Foods Production Act (OFPA), specifically 7 USC §6502 Definitions, §6504 National standards for organic production, and §6509 Animal production practices and materials.
Agriculture: Biotech’s Contributions to Agriculture Sustainability to enhance air, water and soil quality.
March 10, 2016
Read what experts are saying about biotech’s contributions to sustainability